Five‐ versus seven‐day dosing intervals of extended‐release injectable omeprazole in the treatment of equine squamous and glandular gastric disease
Equine Veterinary Journal · 2024-01 · 56 (1) · 51-58
DOI: 10.1111/evj.13938 ↗Kurz gefasst
Fachartikel in der Zeitschrift Equine Veterinary Journal, online erschienen am 19.04.2023. Verfasst von Tania Sundra und 2 weiteren Autor:innen. Beteiligte Einrichtung: Avon Ridge Equine Veterinary Services, Brigadoon, Western Australia, Australia. Hauptthemen laut MEDLINE: Stomach Diseases, Horse Diseases, Carcinoma, Squamous Cell, Stomach Ulcer. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Background
An extended‐release injectable omeprazole formulation (ERIO) has become a popular treatment for equine squamous gastric disease (ESGD) and equine glandular gastric disease (EGGD) where it is available; however, published data are limited and optimal treatment regimens have not been determined.
Objectives
To compare effects of treatment on ESGD and EGGD when an ERIO formulation is administered at either 5‐ or 7‐day intervals. Study design Retrospective clinical study.
Methods
Case records and gastroscopy images of horses with ESGD or EGGD treated with ERIO were reviewed. Images were anonymised and graded by one researcher masked to treatment group. Treatment responses were compared between the two treatment schedules using univariable ordered logistic regression.
Results
Forty‐three horses were treated with ERIO at 5‐day intervals and 39 horses at 7‐day intervals. Signalment and presenting signs did not differ between groups. The proportions of horses with EGGD healing (to grade 0 or 1) in association with ERIO used at 5‐day intervals (93%) were higher than associated with treatment at 7‐day intervals (69%; odds ratio [OR]: 2.41, 95% CI: 1.23–4.74, p = 0.01). For ESGD, there was no significant difference in the proportion of horses healing in association with treatment at 5‐day intervals (97%) compared with 7‐day intervals (82%; OR: 2.75, 95% CI: 0.91–8.31, p = 0.07). Four of 328 injections were associated with an injection‐site reaction (1%). Main limitations Retrospective study design, lack of randomisation and limited case numbers.
Conclusions
The use of ERIO at 5‐day intervals might be more appropriate than the 7‐day interval that is used currently.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Avon Ridge Equine Veterinary Services, Brigadoon, Western Australia, Australia.
- School of Population and Global Health, The University of Western Australia, Crawley, Western Australia, Australia.
- EMT Consulting, Tiverton, Devon, UK.
ORCID-Profile: Tania Sundra, David Rendle
Zitieren
APA
Sundra, T., Kelty, E., & Rendle, D. (2024). Five‐ versus seven‐day dosing intervals of extended‐release injectable omeprazole in the treatment of equine squamous and glandular gastric disease. Equine Veterinary Journal, 56(1), 51-58. https://doi.org/10.1111/evj.13938
Vancouver
Sundra T, Kelty E, Rendle D. Five‐ versus seven‐day dosing intervals of extended‐release injectable omeprazole in the treatment of equine squamous and glandular gastric disease. Equine Veterinary Journal. 2024;56(1):51-58. doi:10.1111/evj.13938
BibTeX
@article{Sundra2024,
author = {Sundra, Tania and Kelty, Erin and Rendle, David},
title = {Five‐ versus seven‐day dosing intervals of extended‐release injectable omeprazole in the treatment of equine squamous and glandular gastric disease},
journal = {Equine Veterinary Journal},
year = {2024},
volume = {56},
number = {1},
pages = {51--58},
doi = {10.1111/evj.13938}
}
EUVIMED